Acute graft-versus-host disease in a nonhematopoietic stem cell transplantation candidate treated with decitabine followed by granulocyte colony-stimulating factor-primed peripheral blood stem cells infusion: A special entity of the disease?

Transfusion

Volumn 54, Issue 1, 2014, Pages 190-193

  Yuan, Lei ^b   Sun, Lu ^b   Yang, Lin ^b   Jing, Yu ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DRB1 ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHIMERA; DISEASE COURSE; DISEASE DURATION; DYSPNEA; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT RECIPIENT; GRAFT VERSUS LEUKEMIA EFFECT; HLA MATCHING; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LYMPHOCYTIC INFILTRATION; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RASH; SKIN BIOPSY; STEM CELL TRANSPLANTATION;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; AZACITIDINE; COMBINED MODALITY THERAPY; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING;

EID: 84891866672     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12215     Document Type: Article

References (9)

1. Dignan FL, Clark A, Amrolia P, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Hadzic N, Shaw BE, Potter MN,; Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation. Diagnosis and management of acute graft-versus-host disease. Br J Haematol 2012; 158: 30-45.
2. Ferrara JL,. Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. J Hematother Stem Cell Res 2000; 9: 299-306. (Pubitemid 30436458)
3. Hummon D, Zantek ND, Sumstad D, Miller JS, McKenna DH,. Transfusion-associated graft-versus-host disease: a perspective from a cell therapy laboratory. Transfusion 2009; 49: 1018-1019.
4. Petz LD, Calhoun L, Yam P, Cecka M, Schiller G, Faitlowicz AR, Herron R, Sayah D, Wallace RB, Belldegrun A,. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors. Transfusion 1993; 33: 742-750. (Pubitemid 23281646)
5. O'Brien KL, Pereira SE, Wagner J, Shadman M, Hendrie P, Nelson K, Gernsheimer TB, Price T, Reyes JD, Nester T,. Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literature. Transfusion 2012; 53: 174-180.
6. Smith DM, Kresie LA,. Preventing transfusion-associated graft-versus-host disease. Transfusion 2007; 47: 173-174; author reply 174.
7. Guo M, Hu KX, Liu GX, Yu CL, Qiao JH, Sun QY, Qiao JX, Dong Z, Sun WJ, Sun XD, Zuo HL, Man QH, Liu ZQ, Liu TQ, Zhao HX, Huang YJ, Wei L, Liu B, Wang J, Shen XL, Ai HS,. HLA-mismatched stem-cell microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-up. J Clin Oncol 2012; 30: 4084-4090.
8. Guo M, Hu KX, Yu CL, Sun QY, Qiao JH, Wang DH, Liu GX, Sun WJ, Wei L, Sun XD, Huang YJ, Qiao JX, Dong Z, Ai HS,. Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients. Blood 2011; 117: 936-941.
9. Hu Y,. Decitabine can increase the induction of regulatory γδ T cells with enhanced immunosuppression on graft-versus-host disease from adult human peripheral blood mononuclear cells. 53rd ASH Annual Meeting and Exposition, December 10-13, 2011.